What a CGRP Non-Responder Is and What Comes Next

Figuring out what to do if CGRP medication doesn't work is one of the more frustrating moments in migraine care. You tried a treatment that works for many people, waited months, and the relief you hoped for never arrived. That doesn't mean you've run out of options. It means you need a clearer picture of what happened and a plan for what comes next.

What "CGRP Non-Responder" Actually Means

CGRP (calcitonin gene-related peptide) plays a central role in migraine attacks. Preventive medications that target this pathway, whether by blocking the peptide itself or its receptor, have helped a significant portion of people with frequent migraines. But response is not universal.

A non-responder is generally someone who completes an adequate trial of a CGRP-targeting therapy and sees no meaningful reduction in migraine frequency or severity. The key word is "adequate." Response takes time, and that's worth understanding before drawing conclusions.

To learn more about how this system works, the CGRP explainer covers the underlying biology in plain language.

Why Some People Don't Respond

There are several plausible reasons, none of which are your fault:

Biological variability. CGRP is one pathway in a complex neurological condition. For some people, other mechanisms are driving the bulk of their attacks. Blocking CGRP then has a limited effect because it isn't the main driver.

Inadequate trial. Non-response after only four or six weeks may be premature. Some people see meaningful improvement only after two to three months of consistent use. Missing doses or stopping early clouds the picture.

Medication overuse. Frequent use of acute headache medications can blunt the effectiveness of preventives, including CGRP therapies. If you've been using acute treatments more than ten days per month, that's worth examining. The medication overuse headache guide explains how this cycle works and what to track, and the medication overuse checker can help you assess your acute use pattern.

Wrong classification. Preventive treatments are calibrated to migraine frequency. If your headache type or frequency has been mischaracterized, the treatment target may be off. Knowing whether you fall into episodic or chronic migraine matters here. The episodic vs. chronic migraine page walks through that distinction, and the chronic or episodic tool lets you check your own pattern.

Partial response that was missed. Some people experience a real but modest reduction and call it failure because their expectations were set higher. Tracking monthly migraine days before and during treatment is the only way to know objectively whether something shifted.

The Difference Between No Response and Partial Response

These are not the same situation.

If you are not sure which category you fall into, you need objective data. Comparing your monthly migraine days before and during treatment is the starting point. Functional impact scores like MIDAS and HIT-6 add another layer. The MIDAS and HIT-6 explainer covers what these scores measure, and you can run your own numbers with the MIDAS calculator or HIT-6 calculator.

What Comes Next: Questions to Bring to Your Neurologist

Non-response is a data point, not a dead end. Your next appointment should be structured around specific questions:

• Was my trial long enough and at the right dose to be a fair test?
• Could medication overuse be affecting the result?
• Am I a partial responder who might benefit from an extended trial or dose change?
• Are there other CGRP-targeting options that work on a different mechanism within the same pathway?
• Should we consider a different drug class entirely, or a combination approach?
• Are there behavioral or lifestyle factors worth addressing alongside any medication change?

Your clinician is the only person who can weigh those options against your history, comorbidities, and prior treatments. The conversation is more productive when you arrive with documented data rather than a general sense that things didn't improve.

The share your migraine log with your doctor guide has practical advice on what to pull together before that appointment.

What Objective Tracking Changes

Neurologists make better decisions with better data. "I still get a lot of headaches" is harder to act on than "I averaged fourteen migraine days per month before treatment and twelve during the past two months."

If you haven't been tracking consistently, now is the time to start. You want to capture:

• Migraine days per month (frequency)
• Attack duration and severity
• Acute medication use and how often you need it
• Functional impact on work, social, and daily activity

The measuring CGRP progress guide explains which metrics matter most and how to present them clearly. The migraine reduction calculator can also show you whether a change in frequency is clinically meaningful.

Prior Authorization and Switching

If your clinician recommends switching to a different option, be aware that prior authorization requirements often apply. Insurers may require documented evidence of a failed trial before approving a different medication in the same class. That's one more reason your logs matter: documentation of what you tried and for how long can directly affect what your insurer will cover. The CGRP prior authorization and renewal guide covers what to expect in that process.

Tracking Through the Uncertainty

Non-response is not rare, and it is not the end of the road. The migraine treatment landscape has more options now than it did even a few years ago, and neurologists have more tools to work with when they have clear, consistent data from patients.

Tracking your attacks, acute medication use, and functional impact inside the Migraine Tracker app gives you exactly the kind of documented record that makes these conversations productive. Before making any change to your preventive or acute treatment, talk with your neurologist. They are the right person to interpret your data and map out the next step.